Intermittent fasting 16:8: what it is and what the trials show
What the 16:8 protocol is, how to do it, who should avoid it, and what the meta-analyses say: the differences versus eating normally are small.
In-depth articles on nutrition and habits, written from systematic reviews, meta-analyses and public guidelines. Each one cites its sources.
What the 16:8 protocol is, how to do it, who should avoid it, and what the meta-analyses say: the differences versus eating normally are small.
Which type of exercise helps you lose more weight according to systematic reviews, why the answer is not "cardio", and what weights do when losing fat.
What the guidelines and the studies say about a sustainable rate of loss, why the internet figures do not hold up, and what to do about plateaus.
What a plateau is, what the scale measures that you cannot see and how far measured metabolic adaptation goes.
Diet composition versus calorie counting, the four WHO principles, fiber and ultra-processed foods with their evidence limits.
Which recovery techniques show an effect according to a review of 99 studies, what it found about massage, cold and heat, and what cannot be promised.
What the WHO fact sheet on alcohol says, the WHO Europe statement on risk, and how to read those figures without turning them into an alarm.
The 10% of daily energy limit, the conditional 5%, exactly what free sugars are, and why the figure does not include whole fruit.
An umbrella review of 201 meta-analyses on coffee and health, the ISSN position stand on performance, and why almost all of it is observational.
The calcium and vitamin D DRI, the dairy meta-analysis with a U-shaped relationship with mortality, and why bone and heart do not match.
The ACSM 60 s per exercise, the critical recalculation of the reviews on stretching, and why the WHO does not mention flexibility.
Moderate and vigorous cardio and the famous Zone 2: what is known about each one and why Zone 2 is not shown to be the best.
The CONSORT and STROBE checklists to judge a trial or an observational study, and the four questions this site asks itself.
Creatine: what the evidence says about strength, muscle mass and cognition, the studied dose, and why the effect is small.
What a calorie deficit is, why guidelines distrust fast weight loss figures, and what diet composition has to do with it.
Breakfast and intermittent fasting: what the trials show and what they do not, and what can actually be claimed with current evidence.
What the controlled trial in 21 men found about long rests, and why this site does not publish an exact number of minutes.
Mediterranean diet: what the evidence says and at what level of certainty, and which part of the pattern is what carries the result.
What reviews show about unsupervised strength training at home, why balance cannot be skipped, and what that means for maximal strength.
Nutrition labeling: what really changes when a label appears, what the Regulation requires, and what can be misread.
The 25 g a day the WHO recommends, where that figure comes from, the difference between soluble and insoluble fiber, and how far the evidence goes.
What strength exercise is associated with health, why the WHO recommendation is 2 or more days per week, and what the limits of the strength evidence are.
What Cochrane says about cutting saturated fat, how the result changes with what replaces it, and why olive oil is not butter.
The 150-300 minutes, strength sessions and the sedentary limit from the 2020 WHO guideline, with its declared evidence limits.
The adequate water intake from the Institute of Medicine, where the 3.7 and 2.7 liters come from, and when thirst is enough.
Iron: why the reference figures are so different between men and women, and what is known about its absorption.
The systematic review comparing intervals with moderate continuous cardio, its exact figures and the four limits you have to read alongside them.
A meta-analysis of 29 cohorts and 1.68 million participants on dairy and mortality, and why yogurt is not the same as milk.
The review with meta-analysis on legumes and cardiometabolic health, the difference between legumes with and without soy, and the limits of the evidence.
Why this site does not publish a list of frequent injuries, which signs refer you to a professional, and what the evidence says about fall prevention.
Why combining balance and strength cuts falls by 34 % and why strength alone does not, with the figures and their certainty levels.
What is known about localized fat reduction, why sweat says nothing, and what the evidence says about the four most repeated beliefs.
What 86 trials with 162,796 people show about omega 3 and cardiovascular disease, and why the advice is still to eat fish.
What the data say about steps and mortality, where the curve appears, why it saturates depending on age, and why 10,000 is not evidence-based.
Why body weight does not measure body composition, what the limits of bioimpedance scales and DEXA are, and what an honest estimate looks like.
What raising the load adds and what periodization adds, why load matters for strength but not hypertrophy, and what the 1RM equation warns about.
The DRI of 0.8 g/kg versus the sports figures: what each number covers, why total weight is a poor basis, and what the limits are.
The meta-analysis that does not confirm a narrow window, why total intake matters more than timing, and what the ISSN position stand stands on.
What the WHO recommends for sodium, what is known about the effect on blood pressure, and why cardiovascular events are not yet solidly established.
Why there is no threshold of minutes seated per day, what the WHO recommends instead, and what certainty limit that recommendation carries.
How much sleep loss hurts performance, which interventions have been tried in athletes.
The NOVA classification applied to foods, the systematic review on steatosis and metabolic syndrome, and why the evidence is almost entirely observational.
The scoping review on B12 in the vegan population, the 50-100 micrograms a day it recommends, the vitamin DRI and the limits of that evidence.
What randomized trials and Mendelian randomization show about vitamin D, the 2011 DRI, and in which groups there is documented benefit.
The dose-response relationship between volume and hypertrophy, its "trend only" limit, and why this site does not name an ideal range.
What the 2024 meta-analysis found on contraceptives and hypertrophy, why there is no reason to change method to train, and what is a medical decision.
What is known about creatine in women: safety measured in 951 participants, the gap where only 9% of studies qualify, and which other effects are unproven.
What the meta-analyses show about strength and the menstrual cycle, why the evidence is weak, and a phase-by-phase plan that is opinion, not a recommendation.
What strength training does for the pain of dysmenorrhea and endometriosis, what the evidence says in endometriosis, and when to stop and get checked.
What is known about the pelvic floor when lifting weights: incontinence prevalence in lifters.
What the lean mass meta-analysis found in PCOS, why the difference is explained by weight, and what the strength training evidence offers.
What the evidence says about returning to strength after childbirth: pelvic floor, rectus diastasis, and why the quality of the studies is low.
Why strength training does not make you "bulky", what the meta-analyses comparing men and women on the same protocol show, and what is left as a difference.
What you gain and how much when you train strength in menopause: the LIFTMOR trial on bone density and what very low certainty does not let us promise.
What is known and what is not about strength training in pregnancy: maternal and fetal outcomes.
What concurrent interference is, what the 2012 meta-analysis says, and what is actually known about whether the interference differs in women.
What energy availability is, what figures the 2025 evidence holds, and why hybrid training is especially prone to dropping below it.
What changes in hybrid training with menopause, what meta-analyses say about strength and bone density, and why the certainty is low.
What you can keep doing with hybrid training during pregnancy according to ACOG, the Canadian guideline and the meta-analyses, and what is still unresolved.
The official HYROX weights and distances by women category, verified at hyrox.com, and which levers the athlete has over them.
What is known and not known about the effect of cycle phase in hybrid training, plus a phase-by-phase plan labeled as opinion.
Incontinence and the pelvic floor in hybrid training: what reviews say about jumps, boxes and heavy loads, and how to order your sessions.
How much protein a woman who trains needs, and what the evidence says about creatine, with the ranges, the limits and what cannot be promised.
What the meta-analyses say about returning to impact training after childbirth, what is evidence and what is waiting without knowing.
What the studies show about sleep and recovery by cycle phase, why symptoms count for more than the phase, and how to use that in your training.
What meta-analyses say about contraceptives and performance, their effect on iron and bone, and what you should ask your doctor.
What ferritin counts as low in a female runner, why iron drops in endurance sport, and what the studies say about taking supplements.
Cycle phases, performance and symptoms: what the studies show, why the evidence is weak, and how to train with your cycle without forcing it.
What prevalence of urine leakage there is in female runners, why impact favors it, and which pelvic floor training has evidence behind it.
What low energy availability and RED-S are, what happens when your period disappears, and what the clinical guidelines say to do about it.
What the most-cited postpartum return-to-running guide says: the 3-6 months, the pelvic floor strength tests, and the list of signs not to start.
What happens to VO2 max and bone in the menopausal transition, what effect running has, and which part of the evidence is weak.
What the largest study of female runners and the pregnancy guidelines show about keeping running through pregnancy, and when to stop.
What share of female runners get breast pain, how it depends on cup size and the bra, and why the pain is not normal.
Which factors are associated with stress fractures in runners, how bone works in women, and what the studies say about calcium and vitamin D.